CureTalks

October 6, 2023

•

8 mins read

TrialX Congratulates Dr. Drew Weissman, Dr. Katalin Karikó and the University of Pennsylvania! – The Nobel Prize Winning mRNA Covid Vaccine Story

The Nobel Prize winning work of the mRNA covid vaccine, has an interesting story that began three decades ago, with a little-known scientist duo who…

758

8 mins read

October 19, 2020

•

2 mins read

CureTalks Launches New Talk Series on Contribution of Small Biotech Companies Towards Drug Development of Orphan Diseases

CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions…

652

2 mins read

July 23, 2020

•

2 mins read

CureTalks launches New Video Format with a talk series on Covid-19 Research at Penn Medicine

We are excited to announce that CureTalks has launched a new format with a talk series on Covid -19 in collaboration with the University…

539

2 mins read

June 17, 2019

•

3 mins read

A WCG Roundtable Sharing the Progress of iConnect Patient Recruitment Platform

Matching the right patient to the right trial remains the most challenging task in the success of any clinical trial. This Clinical Trials day,…

429

3 mins read

December 7, 2018

•

5 mins read

We crossed a milestone! Happy 10th TrialX and Applied Informatics!

October 2018 marks the 10th anniversary of TrialX Inc. and Applied Informatics Inc. Our journey officially began on 12th October, 2008, after we were…

369

5 mins read

April 27, 2018

•

3 mins read

Exclusive Interview with CAR T Cell Therapy Pioneer Dr Carl June – Time’s top 100 Most Influential People in the World

Time magazine named CAR-T cell therapy pioneer Dr Carl June of University of Pennsylvania in their 2018 TIME 100 annual list of the 100…

401

3 mins read

April 4, 2018

•

6 mins read

Social Media in Clinical Trials – How effective?

Without clinical trials we cannot expect to see any advancements in medicine; and to participate in one, patients need to be aware of ongoing…

618

6 mins read

February 4, 2018

•

8 mins read

[Infographic] ASCO Names CAR-T Cell Immunotherapy Clinical Cancer Advance of the Year 2017

CAR T-Cell Immunotherapy has been named Advance of the Year in Annual ASCO Report. Cancer experts looking back over the past 12 months have…

592

8 mins read

November 14, 2017

•

6 mins read

CAR-T Cell Therapy Clinical Trials – Promising Advancement in Medicine

Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed  by Yescarta – in August and October, respectively.…

469

6 mins read